Veracyte (VCYT) is up 26.4%, or $9.55 to $45.67.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VCYT:
- Veracyte price target raised to $43 from $40 at Canaccord
- Veracyte price target raised to $48 from $42 at UBS
- Veracyte’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
- Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating and Increased Price Target
- Veracyte Reports Strong Q3 2025 Financial Performance